GPX4 is a potential diagnostic and therapeutic biomarker associated with diffuse large B lymphoma cell proliferation and B cell immune infiltration

首页 > 成果 > 详情

认领

导出

Link by DOI

反馈

作者信息关键词期刊信息基础信息归属信息摘要

成果类型：

期刊论文

作者：

Chen, Can;Li, Tongyu;Li, Yiwei;Chen, Zhenzhen;Shi, Pengfei;...

通讯作者：

Qian, SX;Li, Y

作者机构：

[Qian, Shenxian; Chen, Zhenzhen; Chen, Can; Shi, Pengfei; Li, Yiwei; Qian, SX] West Lake Univ, Hangzhou Peoples Hosp 1, Sch Med, Dept Hematol, Hangzhou 310006, Zhejiang, Peoples R China.

[Li, Tongyu] Ningbo First Hosp, Dept Hematol, Ningbo, Peoples R China.

[Li, Yun; Li, Yiwei] Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Team Neonatal & Infant Dev Hlth & Nutr, NDHN, Wuhan, Peoples R China.

[Li, Yun] Kindstar Global Precis Med Inst, Wuhan, Peoples R China.

[Li, Yun] Wuhan Kindstar Med Lab Co Ltd, Dept Sci Res Project, Wuhan, Peoples R China.

通讯机构：

[Li, Y ; Qian, SX ] W

West Lake Univ, Hangzhou Peoples Hosp 1, Sch Med, Dept Hematol, Hangzhou 310006, Zhejiang, Peoples R China.

Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Team Neonatal & Infant Dev Hlth & Nutr, NDHN, Wuhan, Peoples R China.

语种：

英文

关键词：

DLBCL;GPX4;Single cells;B cell immune;Biomarker

期刊：

Heliyon

ISSN：

2405-8440

年：

2024

卷：

期：

页码：

e24857

DOI：

10.1016/j.heliyon.2024.e24857

基金类别：

This study was funded by Hangzhou science and technology Major Project with Grant Number: 202004A15, Hangzhou Medical health science and technology Major Project with Grant Number: Z20210039 and Zhejiang Province Traditional Chinese medicine science and technology project with Grant Number: 2023ZR122.

机构署名：

本校为通讯机构

院系归属：

生命科学与技术学院

摘要：

At present, GPX4's role in the occurrence and development of diffuse large B lymphoma (DLBCL) is rarely reported. This study's purpose is to explore GPX4's significance in the diagnosis, treatment, and pathological mechanisms of DLBCL. The TIMER 2.0, GEPIA, and GEO databases were used to analyze GPX4's expression levels in DLBCL tissue, peripheral blood, and single cells, and evaluate its potential performance as a therapeutic and diagnostic marker. Cell experiments validate GPX4's role in DLBCL cells. And revealed the potential mechanism of GP...

反馈

产权有误：本人成果被他人认领

数据有误：数据基本信息有误

归属有误：成果的院系归属、机构署名归属有误

其他原因：

验证码：

看不清楚，换一个

确定

取消

成果认领

标题：

用户	作者	通讯作者	--
	请选择	请选择	--

确定

取消

GPX4 is a potential diagnostic and therapeutic biomarker associated with diffuse large B lymphoma cell proliferation and B cell immune infiltration

反馈

成果认领

提示

该栏目需要登录且有访问权限才可以访问